Correlation Between Inovio Pharmaceuticals and Novavax

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inovio Pharmaceuticals and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inovio Pharmaceuticals and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inovio Pharmaceuticals and Novavax, you can compare the effects of market volatilities on Inovio Pharmaceuticals and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inovio Pharmaceuticals with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inovio Pharmaceuticals and Novavax.

Diversification Opportunities for Inovio Pharmaceuticals and Novavax

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Inovio and Novavax is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Inovio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inovio Pharmaceuticals are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Inovio Pharmaceuticals i.e., Inovio Pharmaceuticals and Novavax go up and down completely randomly.

Pair Corralation between Inovio Pharmaceuticals and Novavax

Considering the 90-day investment horizon Inovio Pharmaceuticals is expected to generate 1.44 times more return on investment than Novavax. However, Inovio Pharmaceuticals is 1.44 times more volatile than Novavax. It trades about 0.03 of its potential returns per unit of risk. Novavax is currently generating about 0.04 per unit of risk. If you would invest  200.00  in Inovio Pharmaceuticals on May 26, 2025 and sell it today you would lose (4.00) from holding Inovio Pharmaceuticals or give up 2.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Inovio Pharmaceuticals  vs.  Novavax

 Performance 
       Timeline  
Inovio Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Inovio Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Inovio Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Novavax 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Novavax are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Novavax may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Inovio Pharmaceuticals and Novavax Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inovio Pharmaceuticals and Novavax

The main advantage of trading using opposite Inovio Pharmaceuticals and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inovio Pharmaceuticals position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.
The idea behind Inovio Pharmaceuticals and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.